Blood Lead Level and Δ-Aminolevulinic Acid Dehydratase Activity in Pre-Menopausal and Postmenopausal Women

Authors

1 Department of Biology, University of Prishtina, Republic of Kosovo

2 Institute of National Public Health, University of PrishtinaP.O.Box 10.000 Prishtinë, Republic of Kosovo

Abstract

To describe the relationship of blood lead levels (BLL) and blood, δ-aminolevulinic acid dehydratase(ALAD) activity and haematocrit value(Hct) to menopause , were examined 17 pre-or perimenopausal (PreM) and 17 postmenopausal women (PosM)from Prishtina City, the capital ofRepublic Kosovo. The mean age of the PreM women was 28.8 years (21-46), with a mean blood lead level of 1.2 μg/dL (SD=0.583 μg/dL ) , the mean blood ALAD activity53.2 U/LE (SD= 2.8 U/LE) and haematocrit value42.1 % (SD= 4.3 %). The mean age of the PosM women was 53.6 years (43-67), with a mean blood lead level1.9 μg/dL (SD=0.94 μg/dL), the mean blood ALAD activity 44.4 U/LE(SD=7.2 U/LE) and haematocrit value 42.1 % ( SD= 4.3 %) and 42.2 % (SD=4.4 %). The BPb level of PosM women was significantly higher (P<0.001) in comparison with the BPb level in PreM women. The blood ALAD activity of PosM was significantly inhibited (P<0.002) in comparison with blood ALAD activity in PreM women. The haematocrit values were relatively unchanged. There was established significantly negative correlation between BPb and blood ALAD activity (r=- 0.605; P<0.01) in the PreM women.These results support the hypothesis that release of bone lead stores increases during menopause and constitutes an internal source of exposure possibly associated with adverse health effects on women in menopause transition.

Keywords

References

Brody D.J., Kramer R.A., et al. Blood lead levels
in the U.S. population. Phase 1of the Third
National Health and Nutritional Examination
Survey (NHABES, 1988to 1991) . JAMA 1994;
.283 -272:277
Silbergeld E.K., Schwartz J., Mahaffey K. 1988.
Lead and osteoporosis: mobilization on lead from
bone in postmenopausal women. Environ Res. 47:
.94 -79
Symanski E., Hertz P.I. 1995. Blood lead level in
relation to menopause, smoking, and pregnancy
history. Am J Epidemiol. 141: .158 -1047
Rabinowitz M.B., Wetherill G.W., Kopple J.D.
: Kinetic analysis of lead metabolism in
healthy humans, J Clin Invest. 58: .270 -260
Robison C.J., Hall J., Beshir S.O. 1983.
Hormonal modulation of mineral metabolism in
reproduction. Proc Nutr Soc. .180 -42:169
Oââ‚‌™Flaherty E.J. 1991. Physiologically models
for bone ââ‚‌“seeking elements. I. Rat skeletal and
bone growth. Toxicol Appl Pharmacol .111:
.312 -299
Oââ‚‌™Flaherty E.J. 1991. Physiologically models
for bone ââ‚‌“seeking elements. II. Kinetics of lead
deposition in rats. Toxicol Appl Pharmacol
.111: .331 -313
Oââ‚‌™Flaherty E.J. 1991. Physiologically models
for bone ââ‚‌“seeking elements. III. Human skeletal
and bone growth. Toxicol Appl Pharmacol.
.341 -111:332
Garel J.M. 1987. Hormonal control of calcium
metabolism during the reproductive cycle in
mammals. Physiol Rev. 67: .66 -1
Berkowitz G.S. Moline J., Todd A.C., 1999.
Methodological issues related to studies of lead
mobilization during menopause. Salud Publica
de Mexico. Vol.41, suplemento 2. s88-s.92
Luckey M., Meier D., Wallenstein S., Lapinski
R. 1992. Racial differences in early
postmenopausal bone loss: A longitudinal
study. J Bone Miner Res. 7: S .140
Silbergeld E., Watson L. 1991. Lead in bone:
implications for toxicology during pregnancy
and lactation. Environ Health Perspect. 91: -63
.70
Rosen J.F., Pounds J.G. 1988. The cellular
metabolism of lead and calcium: a kinetic
analysis in cultured osteoclastic bone cells.
Contrib Nephrol. ,.82 -64:74
Pounds J.G., Long G.J., Rosen J.F. 1991.
Cellular and molecular toxicity of lead in bone .
environ Health Perspect. 91: .32 -17
Pounds J.G. 1984. Effect of lead interaction on
calcium homeostasis and calcium-mediated cell
function: a review. Neurotoxicology. 5: -295
.331
Simons T.J. 1993. Lead-calcium interactions in
cellular lead toxicity. Neurotoxicity. 14: .85 -77
Berglund M., Akesson A., Bjellerup P. , et al.
Metal-bone interactions. Toxicol Lett.
-112: .225 -219
Manton W.I. 1985. Total contribution of
airborne lead to blood lead. Br J Ind Med.
.172 -42:168
Bronner F. 1992. Bone and calcium
homeostasis. Neurotoxicology. 13: .782 -775
Wittmers L.J. Aufderheide A.C. Wallgren J.
Lead in bone. I. Distribution of lead in
human skeleton. Arch Environ Health. 43: -381
.391
Inskip M.J., Franklin C.A., Subramanian K.S.
et. al. 1992. Sampling of cortical and trabecular
bone for lead analysis: method development in
stady of lead mobilization during pregnancy.
Neurotoxicology. 13: .834 -825
Gulson B.L., Mizon K.J., Korsch M.J. et. al.
Mobilization of lead from human bone
tissue during pregnancy and lactation-a
summary of long-term research. Sci Total
Environ. 303: .104 -79
Vahter M., Berglund M., Akesson A., et al.
Metals and womenââ‚‌™s health. Environ Res.
: .155 -145
Lindquist O, Bengtsson C, Hansson T. et al.,
Bone mineral content in relation to age
and menopause in middle-age women: a study
of bone density in lumbar vertebrae by dual
photon absorptiometry in a population sample
of women. Scand J Clin Lab Invest. 41: -215
Riggs B.L., Melton L.D. 1986. Involutional
osteoporosis. N Engl J Med Lancet. 314: -1676
.1686
Sharp D.S., Becker C.E., Smith A.H. 1987.
Chronic low ââ‚‌“ level lead exposure: its role in
the pathogenesis of hypertension. Med Toxicol.
.232 -2:210
Nash D., Magder L., Lustberg M., et al., 2003.
Blood lead , blood pressure and hypertension in
perimenopausal and postmenopausal women.
JAMA. 289: .1532 -1523
Payton M., Riggs K.M, Spiro A. et al. 1988.
Relations of bone and blood lead to cognitive
function. The VA Normative Aging Study.
Neurotoxicol Teratol. 20: .27 -19
Lustberg M., Silbergeld E. 2002. Blood lead
levels and mortality. Arch Intern Med. 162:
. 2449 -2443
Morita Y., Sakai T., Araki T.,
Masuayama.1993. Usefulness of δ-
aminolevulinic acid in blood as an indicator of
lead exposure. Jpn J Ind Health. .118 -35:112
Sakai T. 2000. Biomarkers of Lead Exposure.
Industrial Health.38; .142 -127
.32 Berlin D., Schaller K.K.1974. European
standardized method for the determination of δ-
aminolevulinic acid dehydratase activityin
blood. Z. Klin. Chem. Biochem. 12: .390 -389
Nash D., Magder L.S., Sherwin R., Rubin R.J.
and Silbergeld E.K. 1994. Bone Density-related
Predictions of Blood Lead Level among Periand
Postmenopausal Women in the United
States. American Journal of Epidemiology.
Vol.160, Issue 9; .911 -901
Latorre F.G., Hernandez-Avila M., Orozco J.T.,
medina C.A, Aro A., Palazuelos E., H. H. 2003.
Relationship of Blood and Bone Lead to
Menopause and Bone Mineral density among
Middle-Age Women in Mexico City.
Environmental Health Perspectives. Vol.11, N 0
: 636 -631
Hernandez ââ‚‌“Avila M. Villalapondo VG,
Palazuelos R. et al. 2000. Determinations of
blood and bone lead levels across the
menopausal transition. Arch. Environ Health.
: 360 -355
Sun Y., Sun D., Zhou Z., Zhu G., Zhang H.,
Chang X., Lei L., Jin T. 2008. Osteoporosis in
Chinese Population Due to Occupational
Exposure to Lead. AMERICAN JOURNAL OF
INDUSTRIAL MEDICINE. .442 -51:436
Smith D.R., Osterioh J.D., Fegal A.R. 1996. use
of endogenous stable lead isotope to determine
release of lead from the skeleton. Environ
Health Perspect. .66 -104:60
Murata K., Iwata T., Dakeishi M., Karita K.
Lead Toxicity: Does the Critical Level of
lead Resulting in Adverse Effects Differ
between Adults and Children ?. .12 -51:1
Murata K., Sakai T., Morita Y., Iwata T.,
Dakeishi M. 2003. Critical Dose of Lead
Affecting δ-Aminolevulinic Acid Levels. J
Occup Health. 45: (.214 -209

Files

History

  • Receive Date: 12 July 2012
  • Revise Date: 18 April 2021
  • Accept Date: 29 October 2018

Share

How to cite

Statistics